I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 9 studies | 24% ± 7% | |
| microglial cell | 7 studies | 22% ± 6% | |
| astrocyte | 7 studies | 26% ± 10% | |
| oligodendrocyte | 7 studies | 23% ± 7% | |
| macrophage | 6 studies | 25% ± 5% | |
| epithelial cell | 5 studies | 31% ± 9% | |
| fibroblast | 5 studies | 19% ± 5% | |
| GABAergic neuron | 5 studies | 34% ± 15% | |
| myeloid cell | 4 studies | 18% ± 2% | |
| natural killer cell | 4 studies | 16% ± 1% | |
| abnormal cell | 4 studies | 26% ± 5% | |
| glutamatergic neuron | 4 studies | 45% ± 19% | |
| oligodendrocyte precursor cell | 4 studies | 32% ± 9% | |
| classical monocyte | 3 studies | 24% ± 4% | |
| hematopoietic precursor cell | 3 studies | 20% ± 4% | |
| ciliated cell | 3 studies | 22% ± 1% | |
| lymphocyte | 3 studies | 18% ± 2% | |
| adipocyte | 3 studies | 22% ± 3% | |
| endothelial cell of lymphatic vessel | 3 studies | 19% ± 3% | |
| smooth muscle cell | 3 studies | 17% ± 1% | |
| goblet cell | 3 studies | 27% ± 10% | |
| transit amplifying cell | 3 studies | 26% ± 10% | |
| neuron | 3 studies | 26% ± 9% |
